Vikas Sinha, CPA
President and CFO at AlloVir, an ElevateBio Company
Professional Overview
Vikas Sinha is a seasoned financial executive with extensive experience in the biopharmaceutical industry. As the President and Chief Financial Officer at AlloVir, an ElevateBio Company, he oversees the company's financial strategy, operations, and business development initiatives. Vikas is also the Chief Financial Officer at ElevateBio, where he plays a crucial role in driving the company's growth and expansion.
Experience Summary
Current Role
As the President and CFO of AlloVir, Vikas is responsible for leading the company's financial operations, strategic planning, and business development activities. He has been instrumental in securing funding and partnerships to advance AlloVir's pipeline of novel cell and gene therapies. Under his financial leadership, AlloVir has successfully navigated critical milestones, including the company's initial public offering in 2020.
As the CFO of ElevateBio, Vikas plays a pivotal role in the management and growth of the company's diverse portfolio of biotechnology companies. He oversees the financial operations, capital markets activities, and strategic decision-making that has enabled ElevateBio to become a leading player in the cell and gene therapy sector.
Career Progression
Prior to his current roles, Vikas held senior finance positions at other leading biopharmaceutical companies, including Aegerion Pharmaceuticals and Biogen. He has a proven track record of driving financial performance, securing funding, and leading successful transactions, such as mergers, acquisitions, and strategic partnerships.
Academic Background
Vikas holds a Bachelor of Commerce degree from the University of Delhi and is a Certified Public Accountant (CPA). His educational background and professional certifications have equipped him with a strong foundation in financial management, accounting, and strategic decision-making.
Areas of Expertise
- Financial planning and analysis
- Capital markets and fundraising
- Mergers, acquisitions, and strategic partnerships
- Financial reporting and compliance
- Operational excellence and process optimization
- Biopharmaceutical industry knowledge
Professional Impact
Under Vikas's financial leadership, AlloVir has successfully navigated its transition from a private to a public company, raising significant capital to advance its pipeline of innovative cell and gene therapies. At ElevateBio, he has played a pivotal role in the company's growth, contributing to the expansion of its portfolio and the successful integration of acquired businesses.
Conclusion
Vikas Sinha is a seasoned financial executive with a proven track record of driving growth and operational excellence in the biopharmaceutical industry. His extensive experience, strategic vision, and strong financial acumen make him a valuable asset to both AlloVir and ElevateBio as they continue to push the boundaries of cell and gene therapy innovation.
